HI
IMGN

Harbour Investments’s Immunogen Inc IMGN Stock Holding History

Harbour Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-29
Closed -$460 – 3220
2023
Q3 		$460 Hold
29
– – ﹤0.01% 2814
2023
Q2 		$547 Hold
29
– – ﹤0.01% 2803
2023
Q1 		$111 Sell
29
-22
-43% -$94 ﹤0.01% 2914
2022
Q4 		$253 Hold
51
– – ﹤0.01% 2866
2022
Q3 		$0 Hold
51
– – ﹤0.01% 2871
2022
Q2 		$0 Buy
+51
New +$222 ﹤0.01% 2871
2021
Q4 		$0 Sell
51
-31
-38% -$193 ﹤0.01% 3849
2021
Q3 		$0 Buy
82
+22
+37% +$127 ﹤0.01% 4067
2021
Q2 		$0 Hold
60
– – ﹤0.01% 4032
2021
Q1 		$0 Buy
+60
New +$490 ﹤0.01% 3762

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Harbour Investments's IMGN Position: Q4 2023 in Review

Harbour Investments sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 29 shares — an estimated $460 sold.

Harbour Investments first reported a position in IMGN in Q1 2021 and held it in 10 quarters. The position peaked at $547 in Q2 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Harbour Investments reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Harbour Investments sold 29 Immunogen Inc shares in Q4 2023, an estimated $460.
  • Harbour Investments first reported a position in Immunogen Inc in Q1 2021 and held it in 10 quarters.
  • Harbour Investments's Immunogen Inc position peaked at $547 in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Harbour Investments's 13F filing for Q4 2023, filed 16 Feb 2024.